{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:11:36Z","timestamp":1753891896292,"version":"3.41.2"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Mammalian target of rapamycin inhibitors (mTORi) have been used to treat pediatric tuberous sclerosis complex (TSC)-associated tumors, particularly in cases with contraindications to surgery or difficulties in complete tumor resection. However, some patients experience side effects and tumor regression after discontinuation of the treatment. Therefore, there is an urgent need to develop drugs that can be used in combination with mTORi to increase their efficacy and minimize their side effects. 1,25-Dihydroxyvitamin D<jats:sub>3<\/jats:sub> (1,25-D), which has anticancer properties, may be a promising candidate for adjuvant or alternative therapy because TSC and cancer cells share common mechanisms, including angiogenesis, cell growth, and proliferation. Vitamin D receptor-mediated signaling can be epigenetically modified and plays an important role in susceptibility to 1,25-D. Therefore, vitamin D signaling may be a promising drug target, and <jats:italic>in vitro<\/jats:italic> studies are required to evaluate the efficacy of 1,25-D in TSC-associated tumors, brain development, and core symptoms of psychiatric disorders.<\/jats:p>","DOI":"10.3389\/fped.2024.1392380","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T04:31:25Z","timestamp":1716438685000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Vitamin D in tuberous sclerosis complex-associated tumors"],"prefix":"10.3389","volume":"12","author":[{"given":"Tatsuro","family":"Nobutoki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,5,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"16035","DOI":"10.1038\/nrdp.2016.35","article-title":"Tuberous sclerosis complex","volume":"2","author":"Henske","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B2","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41392-023-01608-z","article-title":"Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease","volume":"8","author":"Panwar","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B3","doi-asserted-by":"publisher","first-page":"630378","DOI":"10.3389\/fneur.2021.630378","article-title":"Tuberous sclerosis registry to increase disease awareness (TOSCA) post-authorisation safety study of everolimus in patients with tuberous sclerosis complex","volume":"12","author":"Kingswood","year":"2021","journal-title":"Front Neurol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s12020-016-0999-1","article-title":"In vitro and in vivo inhibition of mTOR by 1,25-dihydroxyvitamin D3 to improve early diabetic nephropathy via the DDIT4\/TSC2\/mTOR pathway","volume":"54","author":"Wang","year":"2016","journal-title":"Endocrine"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.4161\/cc.10.12.15620","article-title":"Vitamin D: a new player in the world of mTOR signaling","volume":"10","author":"Lisse","year":"2011","journal-title":"Cell Cycle"},{"key":"B6","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/s41416-022-01850-2","article-title":"Vitamin D supplementation and total cancer incidence and mortality by daily vs. infrequent large-bolus dosing strategies: a meta-analysis of randomised controlled trials","volume":"127","author":"Keum","year":"2022","journal-title":"Br J Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41467-020-20368-w","article-title":"A comprehensive reassessment of the association between vitamin D and cancer susceptibility using mendelian randomization","volume":"12","author":"Ong","year":"2021","journal-title":"Nat Commun"},{"key":"B8","doi-asserted-by":"publisher","first-page":"14089","DOI":"10.1038\/s41598-022-17563-8","article-title":"The role of the serum 25-OH vitamin D level on detecting prostate cancer in men with elevated prostate-specific antigen levels","volume":"12","author":"Kim","year":"2022","journal-title":"Sci Rep"},{"key":"B9","doi-asserted-by":"publisher","first-page":"b5500","DOI":"10.1136\/bmj.b5500","article-title":"Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations: a nested case-control study","volume":"340","author":"Jenab","year":"2010","journal-title":"Br Med J"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1111\/bph.15424","article-title":"Vitamin D regulation of energy metabolism in cancer","volume":"179","author":"Sheeley","year":"2022","journal-title":"Br J Pharmacol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1080\/01635581.2015.1073757","article-title":"Association between prediagnostic serum 25-hydroxyvitamin D concentration and glioma","volume":"67","author":"Zigmont","year":"2015","journal-title":"Nutr Cancer"},{"key":"B12","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41374-021-00673-8","article-title":"Anti-tumor effects of vitamin D in glioblastoma: mechanism and therapeutic implications","volume":"102","author":"Lo","year":"2022","journal-title":"Lab Invest"},{"key":"B13","doi-asserted-by":"publisher","first-page":"802334","DOI":"10.3389\/fphar.2022.802334","article-title":"Real-world evidence study on the long-term safety of everolimus in patients with tuberous sclerosis complex: final analysis results","volume":"13","author":"Ruiz-Falc\u00f3 Rojas","year":"2022","journal-title":"Front Pharmacol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"100616","DOI":"10.1016\/j.ctarc.2022.100616","article-title":"Vitamin D and colorectal cancer\u2014a practical review of the literature","volume":"32","author":"Peixoto","year":"2022","journal-title":"Cancer Treat Res Commun"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1101\/gad.1256804","article-title":"Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1\/TSC2 tumor suppressor complex","volume":"18","author":"Brugarolas","year":"2004","journal-title":"Genes Dev"},{"key":"B16","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1096\/fj.10-172577","article-title":"Gene targeting by the vitamin D response element binding protein reveals a role for vitamin D in osteoblast mTOR signaling","volume":"25","author":"Lisse","year":"2011","journal-title":"FASEB J"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1158\/1535-7163.MCT-06-0677","article-title":"1\u03b1,25-dihydroxyvitamin D3 (calcitriol) inhibits hypoxia-inducible factor-1\/vascular endothelial growth factor pathway in human cancer cells","volume":"6","author":"Ben-Shoshan","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"B18","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1161\/01.res.87.3.214","article-title":"1\u03b1,25-dihydroxyvitamin D3 inhibits angiogenesis in vitro and in vivo","volume":"87","author":"Mantell","year":"2000","journal-title":"Circ Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1067\/mjd.2002.120530","article-title":"Tuberous sclerosis-associated lesions of the kidney, brain, and skin are angiogenic neoplasms","volume":"46","author":"Arbiser","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1056\/NEJMc0707517","article-title":"Diagnostic potential of serum VEGF-D for lymphangioleiomyomatosis","volume":"358","author":"Young","year":"2008","journal-title":"N Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12943-020-01288-1","article-title":"Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments","volume":"20","author":"Wei","year":"2021","journal-title":"Mol Cancer"},{"key":"B22","doi-asserted-by":"publisher","first-page":"4749","DOI":"10.1007\/s11033-020-05515-2","article-title":"Vascular mimicry: changing the therapeutic paradigms in cancer","volume":"47","author":"Fathi Maroufi","year":"2020","journal-title":"Mol Biol Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.ajpath.2012.07.013","article-title":"Tumor cell vasculogenic mimicry: from controversy to therapeutic promise","volume":"181","author":"Seftor","year":"2012","journal-title":"Am J Pathol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.cell.2007.05.058","article-title":"IKK\u03b2 suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway","volume":"130","author":"Lee","year":"2007","journal-title":"Cell"},{"key":"B25","doi-asserted-by":"publisher","first-page":"19450","DOI":"10.1074\/jbc.M113.467670","article-title":"Vitamin D receptor inhibits nuclear factor \u03baB activation by interacting with I\u03baB kinase \u03b2 protein","volume":"288","author":"Chen","year":"2013","journal-title":"J Biol Chem"},{"key":"B26","doi-asserted-by":"publisher","first-page":"8704","DOI":"10.1074\/jbc.M608894200","article-title":"Epigenetic silencing of CYP24 in tumor-derived endothelial cells contributes to selective growth inhibition by calcitriol","volume":"282","author":"Chung","year":"2007","journal-title":"J Biol Chem"},{"key":"B27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/bbb\/zbac174","article-title":"Ca2+\/calmodulin induces translocation of membrane-associated TSC2 to the nucleus where it suppresses CYP24A1 expression","volume":"87","author":"Kazami","year":"2022","journal-title":"Biosci Biotechnol Biochem"},{"key":"B28","doi-asserted-by":"publisher","first-page":"5266","DOI":"10.1038\/s41598-019-41744-7","article-title":"Histone deacetylase inhibitors restore normal hippocampal synaptic plasticity and seizure threshold in a mouse model of tuberous sclerosis complex","volume":"9","author":"Basu","year":"2019","journal-title":"Sci Rep"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1681\/ASN.0000000000000146","article-title":"Tuberous sclerosis complex kidney lesion pathogenesis: a developmental perspective","volume":"34","author":"Pietrobon","year":"2023","journal-title":"J Am Soc Nephrol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3389\/fphys.2014.00164","article-title":"Vitamin D and the epigenome","volume":"5","author":"Fetahu","year":"2014","journal-title":"Front Physiol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"44","DOI":"10.4161\/cbt.10.1.11994","article-title":"DNA methylation-related vitamin D receptor insensitivity in breast cancer","volume":"10","author":"Marik","year":"2010","journal-title":"Cancer Biol Ther"},{"key":"B32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11060-014-1416-3","article-title":"Vitamin D receptor expression is associated with improved overall survival in human glioblastoma multiforme","volume":"118","author":"Salom\u00f3n","year":"2014","journal-title":"J Neurooncol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"5249","DOI":"10.3390\/cancers15215249","article-title":"Molecular determinants of calcitriol signaling and sensitivity in glioma stem-like cells","volume":"15","author":"Rehbein","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3577","DOI":"10.3390\/cancers13143577","article-title":"Calcitriol promotes differentiation of glioma stem-like cells and increases their susceptibility to temozolomide","volume":"13","author":"Gerstmeier","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0304-3835(95)04054-4","article-title":"Cytotoxic effects of 1 alpha,25-dihydroxyvitamin D3 and synthetic vitamin D3 analogues on a glioma cell line","volume":"100","author":"Baudet","year":"1996","journal-title":"Cancer Lett"},{"key":"B36","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/(SICI)1097-4547(19980415)52:2%3C210::AID-JNR9%3E3.0.CO;2-D","article-title":"Vitamin D receptor stable transfection restores the susceptibility to 1,25-dihydroxyvitamin D3 cytotoxicity in a rat glioma resistant clone","volume":"52","author":"Davoust","year":"1998","journal-title":"J Neurosci Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1172\/JCI34739","article-title":"Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer","volume":"118","author":"Carracedo","year":"2008","journal-title":"J Clin Invest"},{"key":"B38","doi-asserted-by":"publisher","first-page":"21873","DOI":"10.1038\/s41598-020-78788-z","article-title":"Combined PI3K\u03b1-mTOR targeting of glioma stem cells","volume":"10","author":"Eckerdt","year":"2020","journal-title":"Sci Rep"},{"key":"B39","doi-asserted-by":"publisher","first-page":"956","DOI":"10.3390\/jcm12030956","article-title":"Subependymal giant cell astrocytomas in tuberous sclerosis complex-current views on their pathogenesis and management","volume":"12","author":"Gao","year":"2023","journal-title":"J Clin Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/brain\/awz370","article-title":"The coding and non-coding transcriptional landscape of subependymal giant cell astrocytomas","volume":"143","author":"Bongaarts","year":"2020","journal-title":"Brain"},{"key":"B41","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/toxsci\/kfr203","article-title":"ERK crosstalks with 4EBP1 to activate cyclin D1 translation during quinol-thioether-induced tuberous sclerosis renal cell carcinoma","volume":"124","author":"Cohen","year":"2011","journal-title":"Toxicol Sci"},{"key":"B42","doi-asserted-by":"publisher","first-page":"108586","DOI":"10.1016\/j.steroids.2020.108586","article-title":"Active form of vitamin D analogue mitigates neurodegenerative changes in Alzheimer\u2019s disease in rats by targeting Keap1\/Nrf2 and MAPK-38p\/ERK signaling pathways","volume":"156","author":"Saad El-Din","year":"2020","journal-title":"Steroids"},{"key":"B43","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/s1097-2765(02)00568-3","article-title":"Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase\/akt pathway","volume":"10","author":"Manning","year":"2002","journal-title":"Mol Cell"},{"key":"B44","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jsbmb.2006.04.003","article-title":"Novel gemini-vitamin D3 analog inhibits tumor cell growth and modulates the akt\/mTOR signaling pathway","volume":"100","author":"O\u2019Kelly","year":"2006","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41392-021-00701-5","article-title":"Wnt\/\u03b2-catenin signaling in cancers and targeted therapies","volume":"6","author":"Yu","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B46","doi-asserted-by":"publisher","first-page":"5947","DOI":"10.1074\/jbc.C200473200","article-title":"The tuberin-hamartin complex negatively regulates \u03b2-catenin signaling activity","volume":"278","author":"Mak","year":"2003","journal-title":"J Biol Chem"},{"key":"B47","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/s0002-9440(10)62958-6","article-title":"Aberrant \u03b2-catenin signaling in tuberous sclerosis","volume":"167","author":"Mak","year":"2005","journal-title":"Am J Pathol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.3390\/cancers5041242","article-title":"Vitamin D is a multilevel repressor of wnt\/b-catenin signaling in cancer cells","volume":"5","author":"Larriba","year":"2013","journal-title":"Cancers (Basel)"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1093\/hmg\/dds031","article-title":"MicroRNA-22 is induced by vitamin D and contributes to its antiproliferative, antimigratory and gene regulatory effects in colon cancer cells","volume":"21","author":"Alvarez-D\u00edaz","year":"2012","journal-title":"Hum Mol Genet"},{"key":"B50","doi-asserted-by":"publisher","first-page":"11695","DOI":"10.1038\/s41598-019-48081-9","article-title":"Vitamin D reverts resistance to the mTOR inhibitor everolimus in hepatocellular carcinoma through the activation of a miR-375\/oncogenes circuit","volume":"9","author":"Provvisiero","year":"2019","journal-title":"Sci Rep"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijdevneu.2017.07.002","article-title":"Developmental vitamin D deficiency alters multiple neurotransmitter systems in the neonatal rat brain","volume":"62","author":"Kesby","year":"2017","journal-title":"Int J Dev Neurosci"},{"key":"B52","doi-asserted-by":"publisher","first-page":"240","DOI":"10.9758\/cpn.2023.21.2.240","article-title":"Effects of vitamin D supplementation on children with autism spectrum disorder: a systematic review and meta-analysis","volume":"21","author":"Zhang","year":"2023","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"B53","doi-asserted-by":"publisher","first-page":"6084","DOI":"10.1038\/s41467-021-26131-z","article-title":"mTOR-related synaptic pathology causes autism spectrum disorder-associated functional hyperconnectivity","volume":"12","author":"Pagani","year":"2021","journal-title":"Nat Commun"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1093\/brain\/awad048","article-title":"Epileptogenesis in tuberous sclerosis complex-related developmental and epileptic encephalopathy","volume":"146","author":"Aronica","year":"2023","journal-title":"Brain"},{"key":"B55","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/bpa.12661","article-title":"Oxidative stress and inflammation in a spectrum of epileptogenic cortical malformations: molecular insights into their interdependence","volume":"29","author":"Arena","year":"2019","journal-title":"Brain Pathol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1038\/s41598-017-01207-3","article-title":"In silico evaluation of DNA damage inducible transcript 4 gene (DDIT4) as prognostic biomarker in several malignancies","volume":"7","author":"Pinto","year":"2017","journal-title":"Sci Rep"},{"key":"B57","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3390\/cancers13030499","article-title":"Tumor hypoxia as a barrier in cancer therapy: why levels matter","volume":"13","author":"Hompland","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B58","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s11011-022-01115-0","article-title":"The antidepressant-like effect elicited by vitamin D3 is associated with BDNF\/TrkB-related synaptic protein synthesis","volume":"38","author":"Kouba","year":"2023","journal-title":"Metab Brain Dis"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1073\/pnas.1910834117","article-title":"Trkb hyperactivity contributes to brain dysconnectivity, epileptogenesis, and anxiety in zebrafish model of tuberous sclerosis Complex","volume":"117","author":"Kedra","year":"2020","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1392380\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T04:31:28Z","timestamp":1716438688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1392380\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,23]]},"references-count":59,"alternative-id":["10.3389\/fped.2024.1392380"],"URL":"https:\/\/doi.org\/10.3389\/fped.2024.1392380","relation":{},"ISSN":["2296-2360"],"issn-type":[{"type":"electronic","value":"2296-2360"}],"subject":[],"published":{"date-parts":[[2024,5,23]]},"article-number":"1392380"}}